BioBlast Pharma (ORPN) Tops Q2 EPS by 5c

August 25, 2016 8:11 AM EDT
Get Alerts ORPN Hot Sheet
Trade ORPN Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

BioBlast Pharma (Nasdaq: ORPN) reported Q2 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27).

Cash and cash equivalents (including short-term bank deposits) totaled $15.7 million at June 30, 2016, compared with $19.3 million at December 31, 2015.

For earnings history and earnings-related data on BioBlast Pharma (ORPN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment